These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Quantitative assessment of translocator protein (TSPO) in the non-human primate brain and clinical translation of [ Tan Z; Haider A; Zhang S; Chen J; Wei J; Liao K; Li G; Wei H; Dong C; Ran W; Li Y; Li Y; Rong J; Li Y; Liang SH; Xu H; Wang L Pharmacol Res; 2023 Mar; 189():106681. PubMed ID: 36746361 [TBL] [Abstract][Full Text] [Related]
24. High-risk plaque features can be detected in non-stenotic carotid plaques of patients with ischaemic stroke classified as cryptogenic using combined (18)F-FDG PET/MR imaging. Hyafil F; Schindler A; Sepp D; Obenhuber T; Bayer-Karpinska A; Boeckh-Behrens T; Höhn S; Hacker M; Nekolla SG; Rominger A; Dichgans M; Schwaiger M; Saam T; Poppert H Eur J Nucl Med Mol Imaging; 2016 Feb; 43(2):270-279. PubMed ID: 26433367 [TBL] [Abstract][Full Text] [Related]
25. Imaging the Cytokine Receptor CXCR4 in Atherosclerotic Plaques with the Radiotracer Hyafil F; Pelisek J; Laitinen I; Schottelius M; Mohring M; Döring Y; van der Vorst EP; Kallmayer M; Steiger K; Poschenrieder A; Notni J; Fischer J; Baumgartner C; Rischpler C; Nekolla SG; Weber C; Eckstein HH; Wester HJ; Schwaiger M J Nucl Med; 2017 Mar; 58(3):499-506. PubMed ID: 27789718 [No Abstract] [Full Text] [Related]
26. Towards non-invasive imaging of vulnerable atherosclerotic plaques by targeting co-stimulatory molecules. Müller A; Mu L; Meletta R; Beck K; Rancic Z; Drandarov K; Kaufmann PA; Ametamey SM; Schibli R; Borel N; Krämer SD Int J Cardiol; 2014 Jul; 174(3):503-15. PubMed ID: 24834996 [TBL] [Abstract][Full Text] [Related]
27. [(11)C]DAC-PET for noninvasively monitoring neuroinflammation and immunosuppressive therapy efficacy in rat experimental autoimmune encephalomyelitis model. Xie L; Yamasaki T; Ichimaru N; Yui J; Kawamura K; Kumata K; Hatori A; Nonomura N; Zhang MR; Li XK; Takahara S J Neuroimmune Pharmacol; 2012 Mar; 7(1):231-42. PubMed ID: 22038158 [TBL] [Abstract][Full Text] [Related]
28. Application of 18F-FDG PET for monitoring the therapeutic effect of antiinflammatory drugs on stabilization of vulnerable atherosclerotic plaques. Ogawa M; Magata Y; Kato T; Hatano K; Ishino S; Mukai T; Shiomi M; Ito K; Saji H J Nucl Med; 2006 Nov; 47(11):1845-50. PubMed ID: 17079818 [TBL] [Abstract][Full Text] [Related]
29. Quantification of inflammation within rabbit atherosclerotic plaques using the macrophage-specific CT contrast agent N1177: a comparison with 18F-FDG PET/CT and histology. Hyafil F; Cornily JC; Rudd JH; Machac J; Feldman LJ; Fayad ZA J Nucl Med; 2009 Jun; 50(6):959-65. PubMed ID: 19443582 [TBL] [Abstract][Full Text] [Related]
31. Efficient radiosynthesis and non-clinical safety tests of the TSPO radioprobe [(18)F]FEDAC: Prerequisites for clinical application. Kawamura K; Kumata K; Takei M; Furutsuka K; Hashimoto H; Ito T; Shiomi S; Fujishiro T; Watanabe R; Igarashi N; Muto M; Yamasaki T; Yui J; Xie L; Hatori A; Zhang Y; Nemoto K; Fujibayashi Y; Zhang MR Nucl Med Biol; 2016 Jul; 43(7):445-53. PubMed ID: 27183465 [TBL] [Abstract][Full Text] [Related]
32. Altered choline level in atherosclerotic lesions: Upregulation of choline transporter-like protein 1 in human coronary unstable plaque. Nakamura E; Maekawa K; Saito Y; Matsumoto T; Ogawa M; Komohara Y; Asada Y; Yamashita A PLoS One; 2023; 18(2):e0281730. PubMed ID: 36800352 [TBL] [Abstract][Full Text] [Related]
33. [The value of (18)F-fluorodeoxyglucose positron emission tomography-computed tomography ((18)F-FDG PET-CT) in evaluating the stability of atherosclerotic plaques]. Zhang YH; Tian P; Xu JP; Wang ZZ; Zhao XZ; Nie MX; Zhang MD; Zhao QM; Zhao BT; Song SJ Zhonghua Nei Ke Za Zhi; 2019 Nov; 58(11):808-813. PubMed ID: 31665855 [No Abstract] [Full Text] [Related]
34. 18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial. Joshi NV; Vesey AT; Williams MC; Shah AS; Calvert PA; Craighead FH; Yeoh SE; Wallace W; Salter D; Fletcher AM; van Beek EJ; Flapan AD; Uren NG; Behan MW; Cruden NL; Mills NL; Fox KA; Rudd JH; Dweck MR; Newby DE Lancet; 2014 Feb; 383(9918):705-13. PubMed ID: 24224999 [TBL] [Abstract][Full Text] [Related]
35. (18)F-FDG accumulation in atherosclerotic plaques: immunohistochemical and PET imaging study. Ogawa M; Ishino S; Mukai T; Asano D; Teramoto N; Watabe H; Kudomi N; Shiomi M; Magata Y; Iida H; Saji H J Nucl Med; 2004 Jul; 45(7):1245-50. PubMed ID: 15235073 [TBL] [Abstract][Full Text] [Related]
36. Imaging atherosclerotic plaques by targeting Galectin-3 and activated macrophages using ( Varasteh Z; De Rose F; Mohanta S; Li Y; Zhang X; Miritsch B; Scafetta G; Yin C; Sager HB; Glasl S; Gorpas D; Habenicht AJR; Ntziachristos V; Weber WA; Bartolazzi A; Schwaiger M; D'Alessandria C Theranostics; 2021; 11(4):1864-1876. PubMed ID: 33408786 [No Abstract] [Full Text] [Related]
38. Imaging of atherosclerotic aorta of rabbit model by detection of plaque inflammation with fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography. Zhao QM; Feng TT; Zhao X; Xu ZM; Liu Y; Li DP; Li LQ; Su G; Zhang XX Chin Med J (Engl); 2011 Mar; 124(6):911-7. PubMed ID: 21518602 [TBL] [Abstract][Full Text] [Related]
39. The Availability of the α7-Nicotinic Acetylcholine Receptor in Early Identification of Vulnerable Atherosclerotic Plaques: A Study Using a Novel Wang D; Yao Y; Wang S; Zhang H; He ZX Front Bioeng Biotechnol; 2021; 9():640037. PubMed ID: 33777911 [No Abstract] [Full Text] [Related]
40. In vitro and pilot in vivo imaging of 18 kDa translocator protein (TSPO) in inflammatory vascular disease. Schollhammer R; Lepreux S; Barthe N; Vimont D; Rullier A; Sibon I; Berard X; Zhang A; Kimura Y; Fujita M; Innis RB; Zanotti-Fregonara P; Morgat C EJNMMI Res; 2021 May; 11(1):45. PubMed ID: 33950298 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]